Search
Integra Lifesciences Holdings Corp
IARTAdd to Watchlist
17.580USD
+0.380+2.21%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.37BMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Neurosurgery
827.67M
50.61%
Wound Reconstruction and Care
323.49M
19.78%
Instruments
206.47M
12.63%
ENT
166.37M
10.17%
Private Label
111.25M
6.80%
By RegionUSD
Name
Revenue
Proportion
United States
1.20B
73.67%
Asia Pacific
189.25M
11.57%
Europe
162.67M
9.95%
Rest of World
78.58M
4.81%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Neurosurgery
827.67M
50.61%
Wound Reconstruction and Care
323.49M
19.78%
Instruments
206.47M
12.63%
ENT
166.37M
10.17%
Private Label
111.25M
6.80%
